NCT04744454View on ClinicalTrials.gov

Post Marketing Surveillance (PMS) Study of Cresemba in Korea.

RecruitingOBSERVATIONAL

Enrollment

600

Participants

Timeline

Start Date

October 28, 2021

Primary Completion Date

January 30, 2026

Study Completion Date

January 30, 2026

Conditions

AspergillosisMucormycosis

Interventions

DRUG

Isauvuconazole group

Patients who are treated with Isavuconazole according to its protocol label.

Trial Locations (1)

Unknown

RECRUITING

Pfizer Korea, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY